Manufacturing / Biological Products, Except Diagnostic Substances
aTYR PHARMA INC
ATYR
$0.55
+$0.03 (+4.97%)
Price as of Aug 25, 2026 18:12 UTC
52 M
Market Cap (Micro Cap)
Nov 04
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for ATYR options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
3 buys
3 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| May 27, 2026 | SCHIMMEL PAUL | Buy | 100,000 | $49,630 | |
| May 27, 2026 | SCHIMMEL PAUL | Other | 100,000 | $49,630 | |
| May 11, 2026 | Lucas Svetlana | Grant | 50,000 | $0 | |
| May 11, 2026 | Gross Jane A | Grant | 50,000 | $0 | |
| May 11, 2026 | BENEVICH ERIC | Grant | 50,000 | $0 | |
| May 11, 2026 | Zaknoen Sara | Grant | 50,000 | $0 | |
| May 11, 2026 | Coughlin Timothy | Grant | 50,000 | $0 | |
| May 11, 2026 | SCHIMMEL PAUL | Grant | 50,000 | $0 | |
| May 11, 2026 | Lucas Svetlana | Other | 50,000 | $0 | |
| May 11, 2026 | Gross Jane A | Other | 50,000 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 12, 2026 | Q2 2026 | -$0.12 | |||
| Aug 05, 2026 | Q2 2026 | -$0.12 | |||
| Mar 31, 2026 | Q1 2026 | -$0.14 | -$0.11 | +21.6% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.19 | -$0.14 | +25.3% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.19 | -$0.26 | -38.8% | Miss |
| Jun 30, 2025 | Q2 2025 | -$0.19 | -$0.22 | -17.0% | Miss |
| Mar 31, 2025 | Q1 2025 | -$0.19 | -$0.17 | +12.3% | Beat |
Track ATYR with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ATYR and your entire portfolio.